Predicted protein targets (top 10)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | ABCG2 | Q9UNQ0 | 1/20 | 0.32 |
| ▸ | KEAP1 | Q14145 | 1/20 | 0.32 |
| ▸ | NFE2L2 | Q16236 | 1/20 | 0.32 |
| ▸ | CA1 | P00915 | 2/20 | 0.32 |
| ▸ | CA2 | P00918 | 2/20 | 0.32 |
| ▸ | TSHR | P16473 | 1/20 | 0.32 |
| ▸ | PTGER4 | P35408 | 1/20 | 0.31 |
| ▸ | RORC | P51449 | 1/20 | 0.31 |
| ▸ | TNKS | O95271 | 1/20 | 0.30 |
| ▸ | KDM1A | O60341 | 1/20 | 0.30 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL10038680 | 0.97 | ABCG2 (0.33) | ABCG2KEAP1NFE2L2CA1CA2 | |
| SCHEMBL10038673 | 0.94 | ALDH1A1 (0.39) | ABCG2PTGER4RORC | |
| SCHEMBL12887587 | 0.92 | CA1 (0.35) | ABCG2CA1CA2 | |
| SCHEMBL10038685 | 0.92 | ALDH1A1 (0.31) | ABCG2 | |
| SCHEMBL10038684 | 0.91 | RORC (0.33) | ABCG2RORC | |
| SCHEMBL10068693 | 0.88 | TSHR (0.40) | ABCG2KEAP1NFE2L2CA1CA2 | |
| SCHEMBL10068520 | 0.85 | TSHR (0.42) | ABCG2KEAP1NFE2L2CA1CA2 | |
| SCHEMBL20066925 | 0.83 | ABCG2 (0.30) | ABCG2 | |
| SCHEMBL11886621 | 0.82 | ABCG2 (0.33) | ABCG2KDM1A | |
| SCHEMBL10038771 | 0.82 | TSHR (0.35) | ABCG2CA1CA2TSHRRORC |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 1 patent. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| US-20120013244-A1 | ORGANIC LUMINESCENT MEDIUM | IDEMITSU KOSAN CO., LTD. | 2012-01-19 | — | — | US | disclosed |
Patent text — is the patent's own abstract consistent with the prediction?
For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.
| Patent | Title | Text reads most about | Predicted target · text-rank |
|---|---|---|---|
| US-20120013244-A1 | ORGANIC LUMINESCENT MEDIUM | ANXA1, ANXA11, GLB1 | ABCG2 77/4885KEAP1 1639/4885NFE2L2 510/4885 |
“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.